We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




POC Diagnostic Kits Targeted for Resource-Limited Areas

By LabMedica International staff writers
Posted on 24 Mar 2011
A biotechnology company intends to develop new point of care (POC) diagnostic technologies, which are targeted for use in resource-limited settings.

The technologies will be geared toward the development of noninvasive, urine-based, rapid detection systems for the diagnosis of a panel of sexually transmitted infections, in addition to other diseases such as Tuberculosis.

The company, Norgen Biotek (Thorold, ON, Canada) received over US$800,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP; Ottawa, ON, Canada).

The company focuses primarily on advancing powerful tools for nucleic acids (NA) and protein purification and preservation, as well as developing leading-edge diagnostic tools.

With the new funding Norgen will focus on the development of POC human diagnostic kits for use in resource-limited areas, as well as for home use testing. More...
The new technologies will rely on the use of noninvasive specimens such as urine and saliva for ease of use and cost reduction. Norgen's purification technology is extremely well suited for use in resource-limited settings, as Norgen's resin is able to isolate and concentrate DNA, RNA, and proteins from samples without the use of centrifugation or other equipment.

Norgen has developed technologies and products for the purification of nucleic acids and proteins on both preparative and industrial scales, including ready-to-use chromatography resins and prepacked chromatography columns.

Related Links:

Norgen Biotek
National Research Council of Canada Industrial Research Assistance Program



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Automated Urinalysis Solution
UN-9000
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Microbiology

view channel
Image: The findings suggest that people with mpox can transmit the virus even without clinical symptoms (image credit: Adobe Stock)

Study Finds Hidden Mpox Infections May Drive Ongoing Spread

Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.